Vasopressin in Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 32, Issue 5, 2018, Pages 2225-2232

  Dünser, Martin W ^a   Bouvet, Olivier ^b   Knotzer, Hans ^c   Arulkumaran, Nish ^d   Hajjar, Ludhmila Abrahao ^e   Ulmer, Hanno ^f   Hasibeder, Walter R ^g  

^a JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^b Amomed Pharma GmbH   (Austria)

^c Klinikum Wels   (Austria)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g Krankenhaus St Vinzenz in Zams   (Austria)

Author keywords

acute kidney injury; Arginine vasopressin; atrial fibrillation; cardiac surgery; mortality; perioperative complications; vasodilatory shock

Indexed keywords

ARGIPRESSIN; PLACEBO; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ARTICLE; CLINICAL OUTCOME; DRUG EFFICACY; ELECTIVE SURGERY; EMERGENCY SURGERY; HEART SURGERY; HUMAN; META ANALYSIS; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHOCK; SURGICAL MORTALITY; SYSTEMATIC REVIEW; BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION;

BLOOD PRESSURE; CARDIAC SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 85046804650     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2018.04.006     Document Type: Article

References (22)

1. Fischer, G.W., Levin, M.A., Vasoplegia during cardiac surgery: Current concepts and management. Semin Thorac Cardiovasc Surg 22 (2010), 140–144.
2. Weis, F., Kilger, E., Beiras-Fernandez, A., et al. Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 61 (2006), 938–942.
3. Schmittinger, C.A., Torgersen, C., Luckner, G., et al. Adverse cardiac events during catecholamine vasopressor therapy: A prospective observational study. Intensive Care Med 38 (2012), 950–958.
4. Mayr, A., Knotzer, H., Pajk, W., et al. Risk factors associated with new onset tachyarrhythmias after cardiac surgery – a retrospective analysis. Acta Anaesthesiol Scand 45 (2001), 543–549.
5. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 2998;116:973-980.
6. Dünser, M.W., Mayr, A.J., Stallinger, A., et al. Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med 28 (2002), 746–751.
7. Dünser, M.W., Mayr, A.J., Ulmer, H., et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis. Anesth Analg 93 (2001), 7–13.
8. Morales, D.L., Gregg, D., Helman, D.N., et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 69 (2000), 102–106.
9. Moher, D., Liberati, A., Tetzlaff, J., et al., PRISMA Group. Preferred reporting items for systematic review and meta-analyses: The PRISMA statement. BMJ, 339, 2009, b2535.
10. Dünser, M.W., Mayr, A.J., Ulmer, H., et al. Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 107 (2003), 2313–2319.
11. Morales, D.L., Garrido, M.J., Madigan, J.D., et al. A double-blind randomized trial: Prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 75 (2003), 926–930.
12. Hasija, S., Makhija, N., Choudhury, M., et al. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 24 (2010), 230–238.
13. Papadopoulus, G., Sintou, E., Siminelakis, S., et al. Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting – A double-blind randomized study. J Cardiothorac Surg, 5, 2010, 17.
14. Elgebaly, A.S., Sabry, M., Infusion of low-dose vasopressin improves left ventricular function during separation from cardiopulmonary bypass: A double-blind randomized study. Ann Card Anaesth 15 (2012), 128–133.
15. Okamoto, Y., Nohmi, T., Higa, Y., et al. Vasopressin does not raise cardiac enzymes following cardiac surgery: A randomized double-blind clinical trial. J Cardiothorac Vasc Anesth 29 (2015), 46–51.
16. Hajjar, L.A., Vincent, J.L., Barbosa Gomes Galas, F.R., et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery. The VANCS randomized controlled trial. Anesthesiology 126 (2017), 85–93.
17. Jahangirifard, A., Ergahi, M.G., Fani, K., et al. Effect of prophylactic vasopressin on hemodynamic parameters after coronary artery bypass graft surgery. J Cell Mol Anesth 2 (2017), 97–102.
18. Friesenecker, B.E., Tsai, A.G., Martini, J., et al. Arteriolar vasoconstrictive response: Comparing the effects of arginine vasopressin and norepinephrine. Crit Care, 10, 2006, R75.
19. Qadri, F., Culman, J., Veltmar, A., et al. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus. J Pharmacol Exp Ther 267 (1993), 567–574.
20. Serpa Neto, A., Nassar, A.P., Cardoso, S.O., et al. Vasopressin and terlipressin in adult vasodilatory shock: A systematic review and meta-analysis of nine randomized controlled trials. Crit Care, 16, 2012, R154.
21. Polito, A., Parisini, E., Ricci, Z., et al. Vasopressin for treatment of vasodilatory shock: An ESICM systematic review and meta-analysis. Intensive Care Med 38 (2012), 9–19.
22. Belletti, A., Musu, M., Silvetti, S., et al. Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS One, 10, 2015, e0142605.